Florian Abel Selected Research

Wolman Disease (Wolman's Disease)

1/2022	Long-Term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency.
3/2021	Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies.
1/2021	Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies.
1/2020	Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Florian Abel Research Topics

Disease

4	Wolman Disease (Wolman's Disease) 01/2022 - 01/2020
1	Cholelithiasis 01/2020
1	Cholecystitis 01/2020
1	Melanoma (Melanoma, Malignant) 07/2014
1	Neoplasm Metastasis (Metastasis) 07/2014

Drug/Important Bio-Agent (IBA)

4	Sebelipase alfaIBA 01/2022 - 01/2020
1	EnzymesIBA 01/2021
1	LipidsIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2014

Therapy/Procedure

2	Enzyme Replacement Therapy 03/2021 - 01/2021